Browse studies

Find your next paid study

91 recruiting studies matching your filters

Prospective Validation of the Novel PVD-B65 Risk Score in Patients With Chronic Lung Disease and Pulmonary Hypertension

Prospective observational study to determine if the PVD-B65 risk score for one-year mortality in patients with chronic lung disease and pulmonary hypertension …

Chronic Lung DiseasePulmonary Hypertension

Estimated

~$10 – $750

Actual pay is set by the research site.

Temple UniversityNCT07151768

Phase 1

Feasibility of Semaglutide Therapy for Weight Loss in Advanced Lung Disease: A Pilot Study

The goal of this clinical trial is to learn whether semaglutide, an FDA-approved treatment for diabetes and obesity, is feasible and tolerable in patients with…

ObesityInterstitial Lung DiseaseChronic Obstructive Pulmonary Disease+2 more

Estimated

~$150 – $3,000

Actual pay is set by the research site.

University of PennsylvaniaNCT05746039

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

We propose to acquire data and blood samples on all patients being cared for by the Interstitial Lung Disease (ILD) program. Additionally, we will collect data…

Interstitial Lung DiseasesIdiopathic Pulmonary FibrosisSarcoidosis+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of ChicagoNCT00470327

Phase 1

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

The purpose of this study is to develop and evaluate the usefulness of hyperpolarized (HP) 129Xe gas MRI for regional assessment of pulmonary function.

AsthmaCOPDInterstitial Lung Disease+4 more

Estimated

~$500 – $11,250

Actual pay is set by the research site.

Mario Castro, MD, MPHNCT04624490

A Study of the Natural Progression of Interstitial Lung Disease

Data and specimens will be collected longitudinally from patients seen in the UVA Interstitial Lung Disease (ILD) clinic in order to describe the phenotypic ex…

Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisSarcoidosis+3 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of VirginiaNCT04896138

Phase 2

Emapalumab for the Treatment of Anti-MDA5 Antibody Positive Rapidly Progressive Interstitial Lung Disease

This is a proof of concept study to determine if Emapalumab appears effective for the treatment of anti-MDA5 antibody positive rapidly progressive interstitial…

DermatomyositisDermatomyositis Sine MyositisDermatomyositis With Myopathy+4 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of MiamiNCT07486869

Observational

The Benefits of Home Exercise in Pulmonary Hypertension Interstitial Lung Disease

This study evaluates the effects of a structured home exercise program in participants with pulmonary hypertension associated with interstitial lung disease. P…

Pulmonary HypertensionInterstitial Lung Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

University of RochesterNCT07561034

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those…

Rheumatoid ArthritisInterstitial Lung Disease

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Colorado, DenverNCT03297775

The American Lung Association (ALA) Deep Phenotyping Ancillary Study of the Lung Health Cohort (LHC)

The goal of this observational study is to learn about lung structure and function in a group of 1000 healthy people aged 25 to 35. The main questions it aims …

Lung Diseases

Estimated

~$10 – $750

Actual pay is set by the research site.

Johns Hopkins UniversityNCT06177717

Phase 2

A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate The Efficacy And Safety of Belimumab Administered Subcutaneously in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (SSC-ILD)

This study investigates the efficacy and safety of belimumab compared to placebo, in addition to standard therapy, for the treatment of participants with syste…

Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic

Estimated

~$75 – $3,000

Actual pay is set by the research site.

GlaxoSmithKlineNCT05878717

Phase 2

A Randomized, Double-blind, Placebo Controlled, Dose Escalation Pilot Study Evaluating the Efficacy of Two Doses of Duloxetine and Amitriptyline in Interstitial Lung Disease-related Cough

This research study is evaluating the effectiveness of escalating doses of Amitriptyline and Duloxetine in reducing cough frequency in patients with interstiti…

Interstitial Lung Disease

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Mayo ClinicNCT05120934

Phase 3

A Double-blind, Randomized, Placebo-controlled Trial Investigating the Efficacy and Safety of Nerandomilast Over at Least 52 Weeks in Patients With Fibrosing Interstitial Lung Disease at Risk for Disease Progression (FIBRONEER-ACT)

This study is open to adults with fibrosing interstitial lung disease (ILD) other than idiopathic pulmonary fibrosis (IPF). People can join the study if they h…

Interstitial Lung Diseases

Estimated

~$50 – $2,250

Actual pay is set by the research site.

Boehringer IngelheimNCT07540988